Study of Factors Affecting Onset and Progression of Axial Spondyloarthritis Following Newly Diagnosed Patients to Improve Treatment and Prevention

What this Trial Is About

Researchers are studying axial spondyloarthritis, focusing on understanding the causes of disease onset, its progression, and how treatments affect patients. The study aims to improve treatment options and eventually help prevent the disease. A key focus is on prostaglandin, a substance in the body that may play an inflammatory role in this condition, along with other substances analyzed from blood and urine samples. This is an observational study involving newly diagnosed patients who have not yet received treatment. Participants will be followed for two years after starting treatment. Clinical data, questionnaires, and biological samples like blood and urine will be collected at the start, after one year, and after two years to identify markers that could guide more precise therapies for axial spondyloarthritis. Participants will be involved in regular assessments including clinical evaluations and completing questionnaires over the two-year period. Researchers will monitor prostaglandin levels and other clinical outcomes to better understand the disease course. The study is conducted at two sites and aims to gather detailed information to help tailor future treatments. Total participation lasts for two years from treatment start.

Factors for the Onset and Course of Axial Spondylitis